# Rate Control in Atrial Fibrillation II

> **NCT02695992** · PHASE4 · COMPLETED · sponsor: **Asker & Baerum Hospital** · enrollment: 122 (actual)

## Conditions studied

- Atrial Fibrillation
- Permanent Atrial Fibrillation

## Interventions

- **DRUG:** Metoprolol
- **DRUG:** Diltiazem

## Key facts

- **NCT ID:** NCT02695992
- **Lead sponsor:** Asker & Baerum Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2021-10
- **Final completion:** 2021-11-12
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2022-01-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02695992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02695992, "Rate Control in Atrial Fibrillation II". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02695992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*